Additionally, using the cerebrospinal fluid (CSF) and serum samples taken from MS patients of different stages, IL-6 was found to be the major biomarker in MS, with the highest levels observed in advanced stage MS, that is, secondary progressive MS, compared to primary progressive and relapsingremitting MS [33]. Here, IL6 is linked to myeloid sarcoma.